Asymptomatic SARS-CoV-2 testing: predictors of effectiveness; risk of increasing transmission
View ORCID ProfileJordan P. Skittrall
doi: https://doi.org/10.1101/2020.11.24.20236950
Jordan P. Skittrall
1Department of Applied Mathematics and Theoretical Physics, University of Cambridge, United Kingdom
2Cambridge Clinical Microbiology and Public Health Laboratory, Cambridge, United Kingdom
3Department of Infectious Diseases, Cambridge University Hospitals, Cambridge, United Kingdom
Posted November 24, 2020.
Asymptomatic SARS-CoV-2 testing: predictors of effectiveness; risk of increasing transmission
Jordan P. Skittrall
medRxiv 2020.11.24.20236950; doi: https://doi.org/10.1101/2020.11.24.20236950
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (680)
- Anesthesia (182)
- Cardiovascular Medicine (2693)
- Dermatology (229)
- Emergency Medicine (405)
- Epidemiology (12330)
- Forensic Medicine (10)
- Gastroenterology (772)
- Genetic and Genomic Medicine (4166)
- Geriatric Medicine (392)
- Health Economics (689)
- Health Informatics (2703)
- Health Policy (1010)
- Hematology (366)
- HIV/AIDS (864)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3949)
- Nursing (214)
- Nutrition (587)
- Oncology (2083)
- Ophthalmology (596)
- Orthopedics (245)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (474)
- Pediatrics (1134)
- Primary Care Research (462)
- Public and Global Health (6591)
- Radiology and Imaging (1429)
- Respiratory Medicine (879)
- Rheumatology (415)
- Sports Medicine (345)
- Surgery (456)
- Toxicology (55)
- Transplantation (191)
- Urology (170)